These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 15832087)
1. EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. Yatabe Y; Kosaka T; Takahashi T; Mitsudomi T Am J Surg Pathol; 2005 May; 29(5):633-9. PubMed ID: 15832087 [TBL] [Abstract][Full Text] [Related]
2. Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis. Sumiyoshi S; Yoshizawa A; Sonobe M; Kobayashi M; Sato M; Fujimoto M; Tsuruyama T; Date H; Haga H Lung Cancer; 2014 Jun; 84(3):281-8. PubMed ID: 24725383 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung. Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y Mod Pathol; 2007 Sep; 20(9):967-73. PubMed ID: 17618248 [TBL] [Abstract][Full Text] [Related]
4. Terminal respiratory unit type lung adenocarcinoma is associated with distinctive EGFR immunoreactivity and EGFR mutations. Peterson MR; Piao Z; Bazhenova LA; Weidner N; Yi ES Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):242-7. PubMed ID: 17721266 [TBL] [Abstract][Full Text] [Related]
5. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features. Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264 [TBL] [Abstract][Full Text] [Related]
6. Ciliated adenocarcinomas of the lung: a tumor of non-terminal respiratory unit origin. Park WY; Kim MH; Shin DH; Lee JH; Choi KU; Kim JY; Park DY; Lee CH; Sol MY Mod Pathol; 2012 Sep; 25(9):1265-74. PubMed ID: 22555174 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule. Nakano H; Soda H; Takasu M; Tomonaga N; Yamaguchi H; Nakatomi K; Fujino S; Hayashi T; Nakamura Y; Tsukamoto K; Kohno S Lung Cancer; 2008 Apr; 60(1):136-140. PubMed ID: 17889960 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation. Blons H; Côté JF; Le Corre D; Riquet M; Fabre-Guilevin E; Laurent-Puig P; Danel C Am J Surg Pathol; 2006 Oct; 30(10):1309-15. PubMed ID: 17001163 [TBL] [Abstract][Full Text] [Related]
9. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315 [TBL] [Abstract][Full Text] [Related]
10. Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas. Matsubara D; Soda M; Yoshimoto T; Amano Y; Sakuma Y; Yamato A; Ueno T; Kojima S; Shibano T; Hosono Y; Kawazu M; Yamashita Y; Endo S; Hagiwara K; Fukayama M; Takahashi T; Mano H; Niki T Cancer Sci; 2017 Sep; 108(9):1888-1896. PubMed ID: 28677170 [TBL] [Abstract][Full Text] [Related]
11. [Lung non-terminal respiratory unit type adenocarcinoma: a clinicopathologic study]. Liu B; Wu N; Shen Q; Shi SS; Zhang SS; Ru Y; Rao Q; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):603-608. PubMed ID: 30107665 [No Abstract] [Full Text] [Related]
12. Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. Takeuchi T; Tomida S; Yatabe Y; Kosaka T; Osada H; Yanagisawa K; Mitsudomi T; Takahashi T J Clin Oncol; 2006 Apr; 24(11):1679-88. PubMed ID: 16549822 [TBL] [Abstract][Full Text] [Related]
13. Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features. Finberg KE; Sequist LV; Joshi VA; Muzikansky A; Miller JM; Han M; Beheshti J; Chirieac LR; Mark EJ; Iafrate AJ J Mol Diagn; 2007 Jul; 9(3):320-6. PubMed ID: 17591931 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread. Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features of lung adenocarcinoma with KRAS mutations. Kakegawa S; Shimizu K; Sugano M; Miyamae Y; Kaira K; Araki T; Nakano T; Kamiyoshihara M; Kawashima O; Takeyoshi I Cancer; 2011 Sep; 117(18):4257-66. PubMed ID: 21387273 [TBL] [Abstract][Full Text] [Related]
16. Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas. Matsubara D; Yoshimoto T; Soda M; Amano Y; Kihara A; Funaki T; Ito T; Sakuma Y; Shibano T; Endo S; Hagiwara K; Ishikawa S; Fukayama M; Murakami Y; Mano H; Niki T Cancer Sci; 2020 Jun; 111(6):2183-2195. PubMed ID: 32237253 [TBL] [Abstract][Full Text] [Related]
17. Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma. Brachtel EF; Iafrate AJ; Mark EJ; Deshpande V Diagn Cytopathol; 2007 May; 35(5):257-62. PubMed ID: 17427221 [TBL] [Abstract][Full Text] [Related]